Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Négrier, Sylvie"'
Autor:
Albigès L; Institut Gustave Roussy, Paris, France. Electronic address: laurence.albiges@gustaveroussy.fr., Bellera C; Department of Clinical Epidemiology and Clinical Research, Institut Bergonié, Bordeaux, France., Branchoux S; Department of Health Economics & Outcomes Research, Bristol Myers Squibb, Rueil-Malmaison, France., Arnaud M; IQVIA, Real World Solutions, Bordeaux, France., Gouverneur A; IQVIA, Real World Solutions, Bordeaux, France., Néré S; Department of Medical Affairs, Bristol Myers Squibb, Rueil-Malmaison, France., Gaudin AF; Department of Health Economics & Outcomes Research, Bristol Myers Squibb, Rueil-Malmaison, France., Durand-Zaleski I; AP-HP Hôtel Dieu, Clinical Research Unit Eco Ile de France, Paris, France., Négrier S; Université Lyon I, Centre Léon Bérard, Lyon, France.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2024 Apr; Vol. 22 (2), pp. 295-304.e6. Date of Electronic Publication: 2023 Nov 24.
Autor:
Alhalabi O; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Thouvenin J; Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France.; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Négrier S; Université Lyon I, Centre Léon Bérard, Lyon, France., Vano YA; Hôpital Européen Georges Pompidou, Institut du Cancer Paris CARPEM, AP-HP.Centre-Université de Paris, Paris, France., Campedel L; AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris, France., Hasanov E; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Bakouny Z; Dana-Farber Cancer Institute, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., Hahn AW; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Msaouel P; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Choueiri TK; Dana-Farber Cancer Institute, Boston, MA, USA., Viswanathan SR; Dana-Farber Cancer Institute, Boston, MA, USA., Sircar K; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA., Albiges L; Institut Gustave Roussy, Villejuif, France., Malouf GG; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Tannir NM; The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The oncologist [Oncologist] 2023 May 08; Vol. 28 (5), pp. 433-439.
Autor:
Izarn F; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France. Electronic address: floriane.izarn@lyon.unicancer.fr., Allignet B; University Claude Bernard Lyon 1, Lyon, France; Department of Radiation Oncology, Centre Léon Bérard, Lyon, France; CREATIS, CNRS UMR 5220, Inserm U1206, INSA-Lyon, Université Jean Monnet Saint-Étienne, Université Claude Bernard Lyon1, Villeurbanne, France., Gille R; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France., Boyle H; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Neidhardt EM; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Négrier S; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; University Claude Bernard Lyon 1, Lyon, France., Fléchon A; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2023 Apr; Vol. 21 (2), pp. e35-e43. Date of Electronic Publication: 2022 Sep 24.
Autor:
Thouvenin J; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France.; Institut de Cancérologie des Hospices Civils de Lyon, Lyon, France.; Dana-Farber Cancer Institute (DFCI), Boston, MA, USA., Alhalabi O; MD Anderson Cancer Center (MDACC), Houston, TX, USA., Carlo M; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carril-Ajuria L; Institut Gustave Roussy, Villejuif, France., Hirsch L; Dana-Farber Cancer Institute (DFCI), Boston, MA, USA., Martinez-Chanza N; Institut Jules Bordet, Bruxelles, Belgium., Négrier S; Université Claude Bernard, Centre Léon Bérard, Lyon, France., Campedel L; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Paris, France., Martini D; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Borchiellini D; Antoine Lacassagne Cancer Center, Nice, France., Chahoud J; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA., Lodi M; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Barthélémy P; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France., Hasanov E; MD Anderson Cancer Center (MDACC), Houston, TX, USA., Hahn AW; MD Anderson Cancer Center (MDACC), Houston, TX, USA., Gil T; Institut Jules Bordet, Bruxelles, Belgium., Viswanathan SR; Dana-Farber Cancer Institute (DFCI), Boston, MA, USA., Bakouny Z; Dana-Farber Cancer Institute (DFCI), Boston, MA, USA., Msaouel P; MD Anderson Cancer Center (MDACC), Houston, TX, USA., Asim Bilen M; Winship Cancer Institute of Emory University, Atlanta, GA, USA., Choueiri TK; Dana-Farber Cancer Institute (DFCI), Boston, MA, USA., Albiges L; Institut Gustave Roussy, Villejuif, France., Tannir NM; MD Anderson Cancer Center (MDACC), Houston, TX, USA., Malouf GG; Institut de Cancérologie Strasbourg Europe (ICANS/HUS), Strasbourg, France.
Publikováno v:
The oncologist [Oncologist] 2022 Dec 09; Vol. 27 (12), pp. 1041-1047.
Autor:
Cooley LS; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Rudewicz J; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France.; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France., Souleyreau W; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Emanuelli A; University of Bordeaux, LAMC, Pessac, France.; INSERM U1029, Pessac, France., Alvarez-Arenas A; Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.; Department of Mathematics, Mathematical Oncology Laboratory (MOLAB), Universidad de Castilla-La Mancha, Ciudad Real, Spain., Clarke K; University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK., Falciani F; University of Liverpool, Institute of Systems, Molecular and Integrative Biology, Liverpool, UK., Dufies M; Centre Scientifique de Monaco, Biomedical Department, Principality of Monaco, Monaco.; University Côte d'Azur, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France., Lambrechts D; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Modave E; VIB-KU Leuven Center for Cancer Biology, Leuven, Belgium., Chalopin-Fillot D; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France.; University of Bordeaux, IBGC, Bordeaux, France., Pineau R; University of Bordeaux, 'Service Commun des Animaleries', Bordeaux, France., Ambrosetti D; Centre Hospitalier Universitaire (CHU) de Nice, Hôpital Pasteur, Central laboratory of Pathology, Nice, France., Bernhard JC; Centre Hospitalier Universitaire (CHU) de Bordeaux, service d'urologie, Bordeaux, France., Ravaud A; Centre Hospitalier Universitaire (CHU) de Bordeaux, service d'oncologie médicale, Bordeaux, France., Négrier S; Université de Lyon, Centre Léon Bérard, Lyon, France., Ferrero JM; Centre Antoine Lacassagne, Clinical Research Department, Nice, France., Pagès G; Centre Scientifique de Monaco, Biomedical Department, Principality of Monaco, Monaco.; University Côte d'Azur, Institute for Research on Cancer and Aging of Nice (IRCAN), CNRS UMR 7284; INSERM U1081, Centre Antoine Lacassagne, Nice, France., Benzekry S; Mathematical Modeling for Oncology Team, Inria Bordeaux Sud-Ouest, Talence, France.; COMPO team-project, Inria Sophia Antipolis and CRCM, Inserm U1068, CNRS UMR7258, Aix-Marseille University UM105, Institut Paoli-Calmettes, Marseille, France., Nikolski M; Bordeaux Bioinformatics Center, CBiB, University of Bordeaux, Bordeaux, France.; University of Bordeaux, IBGC, Bordeaux, France., Bikfalvi A; University of Bordeaux, LAMC, Pessac, France. andreas.bikfalvi@u-bordeaux.fr.; INSERM U1029, Pessac, France. andreas.bikfalvi@u-bordeaux.fr.
Publikováno v:
Molecular cancer [Mol Cancer] 2021 Oct 20; Vol. 20 (1), pp. 136. Date of Electronic Publication: 2021 Oct 20.
Autor:
Courcier J; Department of Urology, UPEC-Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France., Dalban C; Centre Leon Bérard, Lyon, France., Laguerre B; Centre Eugene Marquis, Rennes, France., Ladoire S; Centre Georges François Leclerc, Dijon, France., Barthélémy P; Strasbourg University Hospital, Strasbourg, France., Oudard S; Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Joly F; Centre François Baclesse, Caen, France., Gravis G; Medical Oncology Department, Institut Paoli-Calmettes, Aix-Marseille Université, Marseille, France., Chevreau C; Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Geoffrois L; Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France., Deluche É; Limoges University Hospital, Limoges, France., Rolland F; Centre René Gauducheau, Saint Herblain, France., Topart D; Department of Medical Oncology, Montpellier University Hospital, Hôpital Saint Eloi, Montpellier, France., Culine S; Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Négrier S; Centre Leon Bérard, Lyon, France., Mahammedi H; Centre Jean Perrin, Clermont-Ferrand, France., Tantot F; GETUG Group, Unicancer, Paris, France., Jamet A; Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Escudier B; Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Flippot R; Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Albigès L; Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France. Electronic address: laurence.albiges@gustaveroussy.fr.
Publikováno v:
European urology [Eur Urol] 2021 Sep; Vol. 80 (3), pp. 325-329. Date of Electronic Publication: 2021 Jun 05.
Autor:
Barthélémy P; Medical Oncology Department, Institut de cancérologie Strasbourg Europe, Strasbourg University Hospital, Strasbourg, France. Electronic address: p.barthelemy@icans.eu., Rioux-Leclercq N; Department of Pathology, Rennes Hospital, IRSET, Rennes 1 University, France., Thibault C; Medical Oncology Department, Hôpital Européen Georges Pompidou, APHP, Paris, France., Saldana C; Medical Oncology, Hôpital Henri Mondor, APHP, Univ Paris Est Creteil, Créteil, France., Borchiellini D; Medical Oncology Department, Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Chevreau C; ICR IUCT-Oncopole Toulouse, France., Desmoulins I; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France., Gobert A; Medical Oncology Department, Pitié-Salpêtrière Hospital, APHP, Sorbonne University, Paris, France., Hilgers W; Medical Oncology Department, Institut Sainte Catherine, Avignon, France., Khalil A; Medical Oncology Department, Tenon Hospital - APHP, Sorbonne University, Paris, France., Lemoine N; Medical Oncology Department, Clinique Sainte Marie, Cambrai, France., Schlürmann-Constans F; Medical Oncology Department, CHRU Brest, Institut de Cancerologie et Hématologie, CHIC Quimper, France., Négrier S; University of Lyon, Centre Léon Bérard, Lyon, France. Electronic address: sylvie.negrier@lyon.unicancer.fr.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2021 Jun; Vol. 97, pp. 102191. Date of Electronic Publication: 2021 Apr 09.
Autor:
Ruste V; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France. valentine.ruste@live.fr., Sunyach MP; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Tanguy R; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Jouanneau E; Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, 69003, Lyon, France.; Hôpital Pierre Wertheimer, Hospices Civils de Lyon, 59 Boulevard Pinel, 69500, Bron, France., Schiffler C; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Carbonnaux M; Centre Hospitalier Annecy Genevois, 1 avenue de l'hôpital, 74370, Epagny Metz-Tessy, France., Moriceau G; Centre hospitalier Métropole Savoie, place Lucien Biset, 73000, Chambéry, France., Neidhardt EM; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Boyle H; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Robin S; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France., Négrier S; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France.; Université Claude Bernard Lyon 1, 8 Avenue Rockefeller, 69003, Lyon, France., Fléchon A; Centre Léon Bérard, 28 Prom. Lea et Napoleon Bullukian, 69008, Lyon, France.
Publikováno v:
Journal of neuro-oncology [J Neurooncol] 2021 May; Vol. 153 (1), pp. 133-141. Date of Electronic Publication: 2021 Apr 10.
Autor:
Flippot R; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Dalban C; 2Centre Léon Berard, Lyon, France., Laguerre B; 3Centre Eugene Marquis, Rennes, France., Borchiellini D; 4Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France., Gravis G; 5Institut Paoli Calmettes, Marseille, France., Négrier S; 2Centre Léon Berard, Lyon, France., Chevreau C; 6Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France., Joly F; 7Centre François Baclesse, Caen, France., Geoffrois L; 8Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France., Ladoire S; 9Centre Georges François Leclerc, Dijon, France., Mahammedi H; 10Centre Jean Perrin, Clermont-Ferrand, France., Rolland F; 11Centre René Gauducheau, Saint Herblain, France., Gross-Goupil M; 12Bordeaux University Hospital, Bordeaux, France., Deluche E; 13Limoges University Hospital, Limoges, France., Priou F; 14Centre Hospitalier de Vendée, La Roche sur Yon, France., Laramas M; 15Alpes University Hospital, Grenoble, France., Barthélémy P; 16Strasbourg University Hospital, Strasbourg, France., Narciso B; 17Tours University Hospital, Tours, France., Houedé N; 18Nimes University Hospital, Nimes, France., Culine S; 19Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France., Oudard S; 20Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France., Chenot M; 21Université Montpellier, Montpellier, France., Tantot F; 22GETUG Group, Unicancer, Paris, France., Chabaud S; 2Centre Léon Berard, Lyon, France., Escudier B; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France., Albiges L; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Aug 10; Vol. 37 (23), pp. 2008-2016. Date of Electronic Publication: 2019 Jun 13.
Autor:
Négrier S; Univ Lyon, Université Claude Bernard Lyon 1, Lyon, France. sylvie.negrier@lyon.unicancer.fr.; Department of Medical Oncology, Centre Léon Bérard, Lyon, France. sylvie.negrier@lyon.unicancer.fr., Moriceau G; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Attignon V; Department of Translational Research and Innovation, Centre Léon Bérard, Lyon, France., Haddad V; Department of Bio-Pathology, Centre Léon Bérard, Lyon, France., Pissaloux D; Department of Bio-Pathology, Centre Léon Bérard, Lyon, France., Guerin N; Department of Radiology, Centre Léon Bérard, Lyon, France., Carrie C; Department of Radiation Therapy, Centre Léon Bérard, Lyon, France.
Publikováno v:
Journal of medical case reports [J Med Case Rep] 2018 Nov 25; Vol. 12 (1), pp. 351. Date of Electronic Publication: 2018 Nov 25.